Interaction between viral and cell genes in cervical tumors

Molekulyarnaya Biologiya

Volumn 38, Issue 2, 2004, Pages 224-232

  Kisselev, F L ^a   Mazurenko, N N ^a   Volgareva, G M ^a   Kisseleva, N P ^a  

^a N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYCLIN DEPENDENT KINASE; PROTEIN E6; PROTEIN E7; PROTEIN P16INK4A;

ARTICLE; CARCINOGENESIS; CELL ACTIVITY; CHROMOSOME; CHROMOSOME 6; CPG ISLAND; DNA INTEGRATION; GENE INTERACTION; HETEROZYGOSITY LOSS; HUMAN; METHYLATION; MOLECULAR BIOLOGY; ONCOGENE; SOMATIC CELL GENETICS; TUMOR CELL; TUMOR GROWTH; UTERINE CERVIX CANCER; VIRUS GENE; WART VIRUS; DNA METHYLATION; FEMALE; GENETICS; PAPILLOMA VIRUS; REVIEW; UTERINE CERVIX TUMOR; VIROLOGY;

PAPILLOMAVIRIDAE;

DNA METHYLATION; FEMALE; GENES, VIRAL; HUMANS; LOSS OF HETEROZYGOSITY; PAPILLOMAVIRIDAE; UTERINE CERVICAL NEOPLASMS;

EID: 3242875209     PISSN: 00268984     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Zur Hausen H. 2002. Papillomaviruses and cancer: from basic studies to clinical applications. Nature Rev. Cancer. 2, 342-350.
2. Zur Hausen H. 1996. Papillomavirus infection: a major cause of human cancers. Biochim. Biophys. Acta. 1288, F55-F78.
3. Munger K., Phelps W., Bubb V., Howley P., Schelegel R. 1989. The E6 and E7 genes of human papillomavirus type 16 are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63, 4417-4423.
4. Werness B., Levine A., Howley P. 1990. Association of human papillomavirus types 16 and 18 E6 protein with p53. Science. 248, 76-79.
5. Dyson N., Howley P., Munger K., Harlow E. 1989. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 243, 934-937.
6. Matsukura T., Koi S., Sugase M. 1989. Both episomal and integrated forms of human papilloma virus type 16 are involved in invasive cervical cancers. Virology. 172, 63-72.
7. Zur Hausen H. 2000. Papillomavirus causing cancer: evasion from host cell control in early events of carcinogenesis. J. Natl. Cancer Inst. 92, 690-698.
8. Kersemaekers A., van der Vijever M., Kenter G., Fleuren G. 1999. Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix. Genes. Chromos. Cancer. 26, 346-354.
9. ink4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int. J. Cancer. 92, 276-284.
10. Veldman T., Horikawa I., Barrett J., Schlegel R. 2001. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. J. Virol. 75, 4467-4472.
11. Virmani A., Muller K., Rathi A., Zoechbauer-Mueller, Mathis M., Gazdar A. 2001. Aberrant methylation during cervical carcinogenesis. Clin. Cancer Res. 7, 584-589.
12. Dong S., Kim H., Rha S., Sidransky D. 2001. Promotor hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin. Cancer Res. 7, 1982-1986.
13. Samoylova E., Shaikhaev G., Petrov S., Kisseljova N., Kisseljov F. 1995. HPV infection in cervical-cancer cases in Russia. Int. J. Cancer. 61, 337-341.
14. Zumbach K., Kisseljov F., Sacharova O., Shaichaev G., Semjonova L., Pavlova L., Pawlita M. 2000. Antibodies against oncoproteins E6 and E7 of human papillovirus types 16 and 18 in cervical-carcinoma patients from Russia. Int. J. Cancer. 85, 313-318.
15. Klimov E., Vinokourova S., Moisjak E., Rakhmanaliev E., Kobseva V., Laimins L., Kisseljov F., Sulimova G. 2002. Human papilloma viruses and cervical tumors: mapping of integration sites and analysis of adjacent cellular sequences. BMC Cancer. 2, 24-32.
16. Ziegert C., Wentzensen N., Vinokourova S., Kisseljov F., Einenkel J., Hoeckel M., von Knebel Doeberitz M. 2003. A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome based amoplification techniques. Oncogene. 22, 3977-3984.
17. Kisseljov F., Semjonova L., Samoylova E., Mazurenko N., Komissarova E., Zourbitskaya V., Gritzko T., Kozachenko V., Netchuskin M., Petrov S., Smirnov A., Alonso A. 1996. Instability of chromosome 6 microsatellite repeats in human cervical tumors carrying papillomavirus sequences. Int. J. Cancer. 69, 484-487.
18. Mazurenko N., Attaleb M., Gritzko T., Semjonova L., Pavlova L., Sakharova O., Kisseljov F. 1999. High resolution mapping of chromosome 6 deletions in cervical cancer. Oncol. Reports. 6, 859-863.
19. Guo Z., Wu F., Aslund A., Hu X., Mazurenko N., Kisseljov F., Ponten J., Wilander E. 2001. Analysis of intratumoral heterogeneity of chromosome 3p deletions and genetic evidence polyclonal origin of cervical squamous carcinoma. Mod. Pathol. 14, 54-61.
20. Braga E., Pugacheva E., Bazov I., Ermilova V., Kazubskaya T., Mazurenko N., Kisseljov F., Liu J., Garkavtseva R., Zabarovsky E., Kisselev L. 1999. Comparative allelotyping of the short arm of human chromosome 3 in epithelilal tumors of four different types. FEBS Letters. 454, 215-219.
21. Senchenko V., Liu J., Mazurenko N., Loginov V., Serjogin Y., Bazov I., Protopopov A., Kisseljov F., Kashuba V., Lerman M., Klein G., Zabarovsky E. 2003. Deletion mapping using quantitave real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomas. Oncogene. 22, 2984-2992.
22. Ivanova T., Petrenko A., Gritzko T., Vinokourova S., Eshilev E., Kobzeva V., Kisseljov F., Kisseljova N. 2002. Methylation and silencing of the retinoic acid receptor-β2 gene in cervical cancer. BMC Cancer. 2, 4-11.
23. Ivanova T., Vinokourova S., Petrenko A., Solovjova N., Kisseljov F., Kisseljova N. 2003. Frequent hypermethylation of 5′ flanking region of TIMP-2 gene in cervical cancer. Int. J. Cancer. 106, 345-361.
24. Klaes R., Woerner S., Wentzetzen N., Duerst M., Schneider I., Lotz B., Melscheimer P., von Knebel Doeberitz M. 1999. Detection of high risk cervical intraepithelial neoplasias and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res. 59, 6132-6136.
25. Lowe S., Sherr C. 2000. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr. Opin. Gen. Dev. 13, 77-83.